- Poster presentation
- Open Access
Therapeutic hypothermia: pitfalls and pearls
Critical Care volume 9, Article number: P296 (2005)
Materials and methods
We evaluated retrospectively 30 patients after VF-OHCA with regard to complications associated with the use of MIH. MIH was induced by use of a surface cooling protocol and maintained for 12–24 hours. Incidence of koagulopathy, electrolyte disorders, pneumonia (within 72 hours after admission), leukopenia, pancreatitis, hemorrhage, elevated amylase and arrhythmias requiring treatment were documented.
Results and discussion
The median age of the patients was 60.5 years (32–75 years), with all patients (100%) having presumed cardiac cause of OHCA and ventricular fibrillation/pulsless ventricular tachykardia (VF/VT) as the initial ECG rhythm. All patients were intubated at the scene. The presenting arrhythmias during MIH were VF in one patient, VT in two patients and rapid atrial fibrillation in four patients.
MIH is a safe therapy when the clinician is aware of the potential side effects. Electrolyte disorders during MIH and pneumonia after MIH treatment should be anticipated and treated pre-emptively.
Nolan J: Resuscitation. 2003, 57: 231-235. 10.1016/S0300-9572(03)00184-9
Polderman KH: Int Care Med. 2004, 30: 757-769. 10.1007/s00134-003-2151-y
About this article
Cite this article
Busch, M., Søreide, E. Therapeutic hypothermia: pitfalls and pearls. Crit Care 9, P296 (2005). https://doi.org/10.1186/cc3359
- Atrial Fibrillation
- Cardiac Arrest